These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8121331)

  • 21. Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis.
    Pressler T; Jensen ET; Espersen F; Pedersen SS; Høiby N; Koch C
    Pediatr Pulmonol; 1994 Jan; 17(1):31-40. PubMed ID: 8108174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum IgG antibody to outer membrane antigens of Pseudomonas cepacia and Pseudomonas aeruginosa in cystic fibrosis.
    Aronoff SC; Stern RC
    J Infect Dis; 1988 May; 157(5):934-40. PubMed ID: 2452219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human IgG antibodies to Pseudomonas aeruginosa core lipopolysaccharide determinants are detected in chronic but not acute pseudomonas infection.
    Jacobson MA; Radolf JD; Young LS
    Scand J Infect Dis; 1987; 19(6):649-60. PubMed ID: 3126549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.
    Pier GB; Takeda S; Grout M; Markham RB
    J Clin Invest; 1993 Mar; 91(3):1079-87. PubMed ID: 8450038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IgG subclass antibody responses to alginate from Pseudomonas aeruginosa in patients with cystic fibrosis and chronic P. aeruginosa infection.
    Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C
    Pediatr Pulmonol; 1992 Sep; 14(1):44-51. PubMed ID: 1437343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
    Holby N; Olling S
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretory IgA response against Pseudomonas aeruginosa in the upper airways and the link with chronic lung infection in cystic fibrosis.
    Mauch RM; Rossi CL; Aiello TB; Ribeiro JD; Ribeiro AF; Høiby N; Levy CE
    Pathog Dis; 2017 Aug; 75(6):. PubMed ID: 28645157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies in serum and sputum from patients with cystic fibrosis.
    Schiøtz PO; Egeskjold EM; Høiby N; Permin H
    Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA).
    Mauch RM; Rossi CL; Ribeiro JD; Ribeiro AF; Nolasco da Silva MT; Levy CE
    Diagn Pathol; 2014 Aug; 9():158. PubMed ID: 25146522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion.
    Hornick DB; Fick RB
    J Clin Invest; 1990 Oct; 86(4):1285-92. PubMed ID: 2120286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune responses to Aspergillus fumigatus and Pseudomonas aeruginosa antigens in cystic fibrosis and allergic bronchopulmonary aspergillosis.
    Murali PS; Pathial K; Saff RH; Splaingard ML; Atluru D; Kurup VP; Fink JN
    Chest; 1994 Aug; 106(2):513-9. PubMed ID: 7774329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA.
    Pressler T; Pedersen SS; Espersen F; Høiby N; Koch C
    Clin Exp Immunol; 1990 Sep; 81(3):428-34. PubMed ID: 2118845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection.
    Tosi MF; Zakem-Cloud H; Demko CA; Schreiber JR; Stern RC; Konstan MW; Berger M
    J Infect Dis; 1995 Aug; 172(2):453-61. PubMed ID: 7622889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic fibrosis pseudomonas opsonins. Inhibitory nature in an in vitro phagocytic assay.
    Fick RB; Naegel GP; Matthay RA; Reynolds HY
    J Clin Invest; 1981 Oct; 68(4):899-914. PubMed ID: 6793632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered antibody isotype in cystic fibrosis: possible role in opsonic deficiency.
    Moss RB; Hsu YP; Sullivan MM; Lewiston NJ
    Pediatr Res; 1986 May; 20(5):453-9. PubMed ID: 3714355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.
    Anderson TR; Montie TC; Murphy MD; McCarthy VP
    J Clin Microbiol; 1989 Dec; 27(12):2789-93. PubMed ID: 2512326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
    Pressler T; Pandey JP; Espersen F; Pedersen SS; Fomsgaard A; Koch C; Høiby N
    Clin Exp Immunol; 1992 Nov; 90(2):209-14. PubMed ID: 1424275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
    Moss RB; Hsu YP; Lewiston NJ; Curd JG; Milgrom H; Hart S; Dyer B; Larrick JW
    Am Rev Respir Dis; 1986 Apr; 133(4):648-52. PubMed ID: 3083745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.